From Viral Infections to Autistic Neurodevelopmental Disorders via Cross-Reactivity-Journal of Psychiatry and Brain Science-CSCIED科技核心评价数据库-手机版

From Viral Infections to Autistic Neurodevelopmental Disorders via Cross-Reactivity

From Viral Infections to Autistic Neurodevelopmental Disorders via Cross-Reactivity

ES评分 0 浏览量：696 下载量：0

DOI	10.20900/jpbs.20180014
刊名	Journal of Psychiatry and Brain Science JPBS
年，卷(期)	2018, 3(6)
作者	Darja Kanduc*,Anna Polito,
作者单位	1 Department of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari, Bari 70125, Italy; ; 2 Complex Structure of Neuropsychiatry Childhood-Adolescence, United Hospitals of Foggia, Foggia 71122, Italy.
Abstract	Objective: Genetic, epigenetic, and environmental factors such as infections have been proposed as potential causes of autism spectrum disorder (ASD). Searching for the molecular mechanism by which infections might contribute to the etiopathogenesis of ASD, we analyze here the hypothesis that immune responses to infectious agents may cross-react with human proteins that, when altered, relate to autistic neurodevelopmental spectrum disorders. Methods: Viral and human proteins were analyzed for peptide sharing using the Pir Peptide Match resource. Results: We find that: (i) an intense peptide overlap occurs between ASD–related viruses and ASD–related human proteins, and might underlie cross-reactivity scenarios following viral infections; (ii) viral peptide sharing also occurs with Y-linked proteins, in this way highlighting an additional potential cross-reactivity burden that would involve male subjects only; (iii) many shared peptides are also part of epitopes experimentally validated as immunopositive in the human host. Conclusion: This study offers a cohesive set of data that suggests a contribution of immune cross-reactivity to the genesis of ASD.
KeyWord	autism spectrum disorders; viral infections; peptide cross-reactivity; autism-related proteins; Y-linked proteins
基金项目
页码	-

参考文献
相关文献

1.National Collaborating Centre for Mental Health (UK). Autism: the management and support of children and young people on the autism spectrum. Leicester (UK): British Psychological Society. (NICE Clinical Guidelines, No. 170). Available from: https://www.ncbi.nlm.nih.gov/books/NBK299062/2013. Accessed 2018 March 1.

2.Hornig M, Mervis R, Hoffman K, Lipkin WI. Infectious and immune factors in neurodevelopmental damage. Mol Psychiatry. 2002; 7: S34-S35.

3.Karim S, Mirza Z, Kamal MA, Abuzenadah AM, Azhar EI, Al-Qahtani MH, et al. The role of viruses in neurodegenerative and neurobehavioral diseases. CNS Neurol Disord Drug Targets. 2014; 13: 1213-1223.

4.Abdallah MW, Hougaard DM, Nørgaard-Pedersen B, Grove J, Bonefeld-Jørgensen EC, Mortensen EL. Infections during pregnancy and after birth, and the risk of autism spectrum disorders: a register-based study utilizing a Danish historic birth cohort. Turk Psikiyatri Derg. 2012; 23: 229-235.

5.Hornig M, Weissenböck H, Horscroft N, Lipkin WI. An infection-based model of neurodevelopmental damage. Proc Natl Acad Sci USA. 1999; 96: 12102-12107.

6.Estes ML, McAllister AK. Maternal immune activation: Implications for neuropsychiatric disorders. Science. 2016; 353: 772-777.

7.Blaylock RL, Strunecka A. Immune-glutamatergic dysfunction as a central mechanism of the autism spectrum disorders. Curr Med Chem. 2009; 16: 157-170.

8.Braunschweig D, Krakowiak P, Duncanson P, Boyce R, Hansen, RL, Ashwood P, et al. Autism-specific maternal autoantibodies recognize critical proteins in developing brain. Transl Psychiatry. 2013; 3: e277.

9.Desai A, Sequeira JM, Quadros EV. Prevention of behavioral deficits in rats exposed to folate receptor antibodies: implication in autism. Mol Psychiatry. 2017; 22: 1291-1297.

10.Edmiston E, Ashwood P, Van de Water J. Autoimmunity, autoantibodies, and autism spectrum disorder. Biol Psychiatry. 2017; 81: 383-390.

11.Elamin NE, Al-Ayadhi LY. Brain autoantibodies in autism spectrum disorder. Biomark Med. 2014; 8: 345-352.

12.Goines P, Haapanen L, Boyce R, Duncanson P, Braunschweig D, Delwiche L, et al. Autoantibodies to cerebellum in children with autism associate with behavior. Brain Behav Immun. 2011; 25: 514-523.

13.Mader S, Brimberg L, Diamond B. The role of brain-reactive autoantibodies in brain pathology and cognitive impairment. Front Immunol. 2017; 8: 1101.

14.Mead J, Ashwood P. Evidence supporting an altered immune response in ASD. Immunol Lett. 2015; 163: 49-55.

15.Masi A, Quintana DS, Glozier N, Lloyd AR, Hickie IB, Guastella AJ. Cytokine aberrations in autism spectrum disorder: a systematic review and meta-analysis. Mol Psychiatry. 2015; 20(4):440-446.

16.Onore C, Careaga M, Ashwood P. The role of immune dysfunction in the pathophysiology of autism. Brain Behav Immun. 2012; 26: 383-392.

17.Piras IS, Haapanen L, Napolioni V, Sacco R, Van de Water J, Persico AM. Anti-brain antibodies are associated with more severe cognitive and behavioural profiles in Italian children with Autism Spectrum Disorder. Brain Behav Immun. 2014; 38: 91-99.

18.Rout UK, Dhossche DM. A pathogenetic model of autism involving Purkinje cell loss through anti-GAD antibodies. Med Hypotheses. 2008; 71: 218-221.

19.Wills S, Cabanlit M, Bennett J, Ashwood P, Amaral D, Van de Water J. Autoantibodies in autism spectrum disorders (ASD). Ann N Y Acad Sci. 2007; 1107: 79-91.

20.Wills S, Cabanlit M, Bennett J, Ashwood P, Amaral DG, Van de Water J. Detection of autoantibodies to neural cells of the cerebellum in the plasma of subjects with autism spectrum disorders. Brain Behav Immun. 2009; 23: 64-74.

21.Wojcik S, Bernatsky S, Platt RW, Pineau CA, Clarke AE, Fombonne É, et al. Risk of autism spectrum disorders in children born to mothers with rheumatoid arthritis: A systematic literature review. Arthritis Care Res. 2017; 69: 1926-1931.

22.Walsh D, Mohr I. Viral subversion of the host protein synthesis machinery. Nat Rev Microbiol. 2011; 9: 860-875.

23.Alix E, Mukherjee S, Roy CR. Subversion of membrane transport pathways by vacuolar pathogens. J Cell Biol. 2011; 195: 943-952.

24.Tomasec P, Braud VM, Rickards C, Powell MB, McSharry BP, Gadola S, et al. Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. Science. 2000; 287: 1031.

25.Ulbrecht M, Martinozzi S, Grzeschik M, Hengel H, Ellwart JW, Pla M, et al. Cutting edge: the human cytomegalovirus UL40 gene product contains a ligand for HLA-E and prevents NK cell mediated lysis. J Immunol 2000; 164: 5019-5022.

26.Wilkinson GW, Tomasec P, Stanton RJ, Armstrong M, Prod'homme V, Aicheler R, et al. Modulation of natural killer cells by human cytomegalovirus. J Clin Virol. 2008; 41: 206-212.

27.Baron-Cohen S, Lombardo MV, Auyeung B, Ashwin E, Chakrabarti B, Knickmeyer R. Why are autism spectrum conditions more prevalent in males? PloS Biol. 2011; 9: e1001081.

28.Werling DM, Geschwind DH. Sex differences in autism spectrum disorders. Curr Opin Neurol. 2013; 26: 146-153.

29.Palmer N, Beam A, Agniel D, Eran A, Manrai A, Spettell C, et al. Association of sex with recurrence of autism spectrum disorder among siblings. JAMA Pediatr. 2017; 171: 1107-1112.

30.Natale C, Giannini T, Lucchese A, Kanduc D. Computer-assisted analysis of molecular mimicry between HPV16 E7 oncoprotein and human protein sequences. Immunol Cell Biol. 2000; 78: 580-585.

31.Kanduc D, Stufano A, Lucchese G, Kusalik A. Massive peptide sharing between viral and human proteomes. Peptides. 2008; 29: 1755-1766.

32.Kanduc D. Peptide cross-reactivity: the original sin of vaccines. Front Biosci. 2012; 4: 1393-1401.

33.Kanduc D. Measles virus hemagglutinin epitopes are potential hotspots for crossreactions with immunodeficiency-related proteins. Future Microbiol. 2015; 10: 503-515.

34.Kanduc D. Influenza and sudden unexpected death: the possible role of peptide cross-reactivity. Infect Int. Forthcoming 2019.

35.Lucchese G, Kanduc D. The Guillain–Barrè peptide signatures: from Zika virus to Campylobacter, and beyond. Virus Adapt Treat. 2017; 9: 1–11.

36.Lucchese G, Kanduc D. Cytomegalovirus infection: the neurodevelopmental peptide signatures. Curr Drug Discov Technol. 2018; 15: 251-262.

37.Polito A, Polimeno R, Kanduc D. Peptide sharing between Parvovirus B19 and DNA methylating/ histone modifying enzymes. a potential link to childhood acute lymphoblastic leukemia. Int J Ped Child Health. 2017; 1: 29-39.

38.Pletnikov MV, Moran TH, Carbone KM. Borna disease virus infection of the neonatal rat: developmental brain injury model of autism spectrum disorders. Front Biosci. 2002; 7: 593-607.

39.Lancaster K, Dietz DM, Moran TH, Pletnikov MV. Abnormal social behaviors in young and adult rats neonatally infected with Borna disease virus. Behav Brain Res. 2007; 176: 141-148.

40.Honda T, Sofuku K, Matsunaga H, Tachibana M, Mohri I, Taniike M, Tomonaga K. Prevalence of antibodies against Borna disease virus proteins in Japanese children with autism spectrum disorder. Microbiol Immunol. 2018. doi: https://doi.org/10.1111/1348-0421.12603.

41.Singh VK, Lin SX, Newell E, Nelson C. Abnormal measles-mumps-rubella antibodies and CNS autoimmunity in children with autism. J Biomed Sci. 2002; 9: 359-364.

42.Deykin E, Mac Mahon B. Viral exposure and autism. Am J Epidemiol. 1979; 109: 628-638.

43.Chess S, Fernandez P, Korn S. Behavioral consequences of congenital rubella. J Pediatr. 1978; 93: 699-703.

44.Hutton J. Does rubella cause autism: a 2015 reappraisal? Front Hum Neurosci. 2016; 10: 25.

45.Singh VK. Phenotypic expression of autoimmune autistic disorder (AAD): a major subset of autism. Ann Clin Psychiatry. 2009; 21: 148-61.

46.Hwang SJ, Chen YS. Congenital rubella syndrome with autistic disorder. J Chin Med Assoc. 2010; 73: 104-107.

47.Dyken PR. Neuroprogressive disease of post-infectious origin: a review of a resurging subacute sclerosing panencephalitis (SSPE). Ment Retard Dev Disabil Res Rev. 2001; 7: 217-225.

48.Singh VK, Jensen RL. Elevated levels of measles antibodies in children with autism. Pediatr Neurol. 2003; 28: 292-294.

49.Fatemi SH, Earle J, Kanodia R, Kist D, Emamian ES, Patterson PH, et al. Prenatal viral infection leads to pyramidal cell atrophy and macrocephaly in adulthood: implications for genesis of autism and schizophrenia. Cell Mol Neurobiol. 2002; 22: 25-33.

50.Atladóttir HÓ, Henriksen TB, Schendel DE, Parner ET. Autism after infection, febrile episodes, and antibiotic use during pregnancy: an exploratory study. Pediatrics. 2012; 130: e1447-1454.

51.Fatemi SH, Folsom TD, Liesch SB, Kneeland RE, Karkhane Yousefi M, Thuras PD, et al. The effects of prenatal H1N1 infection at E16 on FMRP, glutamate, GABA, and reelin signaling systems in developing murine cerebellum. J Neurosci Res. 2017; 95: 1110-1122.

52.Chen C, Huang H, Wu CH. Protein bioinformatics databases and resources. Methods Mol Biol. 2017; 1558: 3-39.

53.Skaletsky H, Kuroda-Kawaguchi T, Minx PJ, Cordum HS, Hillier L, Brown LG, et al. The male-specific region of the human Y chromosome is a mosaic of discrete sequence classes. Nature. 2003; 423: 825-837.

54.Vita R, Overton JA, Greenbaum JA, Ponomarenko J, Clark JD, Cantrell JR, et al. The immune epitope database (IEDB) 3.0. Nucleic Acids Res. 2015; 43: D405-D412.

55.Uhlén M, Fagerberg L, Hallström BM, Lindskog C, Oksvold P, Mardinoglu A, et al. Proteomics. Tissue-based map of the human proteome. Science. 2015; 347: 1260419.

56.Thul PJ, Åkesson L, Wiking M, Mahdessian D, Geladaki A, Ait Blal H, et al. A subcellular map of the human proteome. Science. 2017; 356: pii:eaal3321.

57.Kerr JR. The role of parvovirus B19 in the pathogenesis of autoimmunity and autoimmune disease. J Clin Pathol. 2016; 69: 279-291.

58.Niman HL, Houghten RA, Walker LE, Reisfeld RA, Wilson IA, Hogle JM, et al. Generation of protein-reactive antibodies by short peptides is an event of high frequency: implications for the structural basis of immune recognition. Proc Natl Acad Sci USA. 1983; 80: 4949-4953 and references therein.

59.Ewing C, Ebringer R, Tribbick G, Geysen HM. Antibody activity in ankylosing spondylitis sera to two sites on HLA B27.1 at the MHC groove region (within sequence 65-85), and to a Klebsiella pneumoniae nitrogenase reductase peptide (within sequence 181-199). J Exp Med. 1990; 171: 1635-1647 and references therein.

60.Schwimmbeck PL, Oldstone MB. Molecular mimicry between human leukocyte antigen B27 and Klebsiella. Consequences for spondyloarthropathies. Am J Med. 1988; 85: 51-53 and references therein.

61.Oldstone MB. Molecular mimicry and immune-mediated diseases. FASEB J. 1998; 12: 1255-1265 and references therein.

62.Lee CL, Atassi MZ. Enzymic and immunochemical properties of lysozyme. Accurate definition of the antigenic site around the disulphide bridge 30-115 (site 3) by 'surface-simulation' synthesis. Biochem J. 1977; 167: 571-581 and references therein.

63.Reddehase MJ, Rothbard JB, Koszinowski UH. A pentapeptide as minimal antigenic determinant for MHC class I-restricted T lymphocytes. Nature. 1989; 337: 651–653 and references therein.

64.Rothbard JB, Gefter ML. Interactions between immunogenic peptides and MHC proteins. Annu Rev Immuno. 1991; 9: 527–565 and references therein.

65.Liebers V, Raulf M, Mazur G, Modrow S, Baur X. Epitope mapping with peptides of Chi t I component III and immunomodulation of the Chi t immune response. J Allergy Clin Immunol. 1993; 92: 334–339 and references therein.

66.Moran E, Simmons C, Vinh Chau N, Luhn K, Wills B, Dung NP, et al. Preservation of a critical epitope core region is associated with the high degree of flaviviral cross-reactivity exhibited by a dengue-specific CD4+ T-cell clone. Eur J Immunol. 2008; 38: 1050–1057 and references therein.

67.Godkin AJ, Thomas HC, Openshaw PJ. Evolution of epitope-specific memory CD4(+) T-cells after clearance of hepatitis C virus. J Immunol. 2002; 169: 2210–2214 and references therein.

68.Gulden PH, Fischer P, Sherman NE, Wang W, Engelhard VH, Shabanowitz J, et al. A Listeria monocytogenes pentapeptide is presented to cytolytic T lymphocytes by the H2-M3 MHC class Ib molecule. Immunity. 1996; 5: 73–79 and references therein.

69.Zagury JF, Bernard J, Achour A, Astgen A, Lachgar A, Fall L, et al. HIV-1-induced immune suppression may result from autoimmune disorders including anti-SLWDQ autoantibodies. Biomed Pharmacother. 1993; 47: 93–99 and references therein.

70.Frank A. Immunology and Evolution of Infectious Disease. Princeton, NJ: Princeton University Press, 2002 and references therein.

71.Zeng W, Pagnon J, Jackson DC. The C-terminal pentapeptide of LHRH is a dominant B cell epitope with antigenic and biological function. Mol Immunol. 2007; 44: 3724–3731 and references therein.

72.Endo M, Nunomura W, Takakuwa Y, Hatakeyama M, Higashi T. A novel epitope (pentapeptide) in the human hemoglobin beta chain. Hemoglobin. 1998; 22: 321-331 and references therein.

73.Tiwari R, Geliebter J, Lucchese A, Mittelman A, Kanduc D. Computational peptide dissection of Melan-a/MART-1 oncoprotein antigenicity. Peptides. 2004; 25: 1865-1871 and references therein.

74.Kishimoto J, Fukuma Y, Mizuno A, Nemoto TK. Identification of the pentapeptide constituting a dominant epitope common to all eukaryotic heat shock protein 90 molecular chaperones. Cell Stress Chaperones. 2005; 10: 296-311 and references therein.

75.Wasniowska K, Petit-LeRoux Y, Tournamille C, Le van Kim C, Cartron JP, Colin Y, et al. Structural characterization of the epitope recognized by the new anti-Fy6 monoclonal antibody NaM 185-2C3. Transfus Med. 2002; 12: 205-211 and references therein.

76.Tanabe S. Epitope peptides and immunotherapy. Curr Protein Pept Sci. 2007; 8: 109-118 and references therein.

77.Plewnia G, Schulze K, Hunte C, Tampé R, Koch J. Modulation of the antigenic peptide transporter TAP by recombinant antibodies binding to the last five residues of TAP1. J Mol Biol. 2007; 369: 95-107 and references therein.

78.Stufano A, Kanduc D. Proteome-based epitopic peptide scanning along PSA. Exp Mol Pathol. 2009; 86: 36-40 and references therein.

79.Kanduc D. Homology, similarity, and identity in peptide epitope immunodefinition. J Pept Sci. 2012; 18: 487-494 and references therein.

80.Raychaudhuri S, Sandor C, Stahl EA, Freudenberg J, Lee HS, Jia X, et al. Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis. Nat Genet. 2012; 44: 291-296 and references therein.

81.Kanduc D. Pentapeptides as minimal functional units in cell biology and immunology. Curr Protein Pept Sci. 2013; 14: 111-120 and references therein.

82.Xiao N, Cao J, Zhou H, Ding SQ, Kong LY, Li JN. Identification of three novel B-cell epitopes of VMH protein from Vibrio mimicus by screening a phage display peptide library. Vet Immunol Immunopathol. 2016; 182: 22-28 and references therein.

83.El-Turk F, Newby FN, De Genst E, Guilliams T, Sprules T, Mittermaier A, et al. Structural effects of two camelid nanobodies directed to distinct C-terminal epitopes on α-Synuclein. Biochemistry. 2016; 55: 3116-3122 and references therein.

84.Cui Z, Zhao MH, Jia XY, Wang M, Hu S, Wang S, et al. Antibodies to α5 chain of collagen IV are pathogenic in Goodpasture's disease. J Autoimmun. 2016; 70: 1-11 and references therein.

85.Li Z, Wang D, Gu Y, Song S, He M, Shi J, et al. Crystal structures of two immune complexes identify determinants for viral infectivity and type-specific neutralization of human papillomavirus. MBio. 2017; 8: e00787-e007817 and references therein.

86.Kanduc D. The comparative biochemistry of viruses and humans: an evolutionary path towards autoimmunity. Biol Chem. 2018. doi:10.1515/hsz-2018-0271.

87.Kaeser MD, Aslanian A, Dong MQ, Yates JR, Emerson BM. BRD7, a novel PBAF-specific SWI/SNF subunit, is required for target gene activation and repression in embryonic stem cells. J Biol Chem. 2008; 283: 32254-32263.

88.Nagl NG, Wang X, Patsialou A, Van Scoy M, Moran E. Distinct mammalian SWI/SNF chromatin remodeling complexes with opposing roles in cell-cycle control. EMBO J. 2007; 26: 752–763.

89.Ka M, Chopra DA, Dravid SM, Kim WY. Essential Roles for ARID1B in dendritic arborization and spine morphology of developing pyramidal neurons. J Neurosci. 2016; 36: 2723-2742.

90.Hoyer J, Ekici AB, Endele S, Popp B, Zweier C, Wiesener A, et al. Haploinsufficiency of ARID1B, a member of the SWI/SNF-a chromatin-remodeling complex, is a frequent cause of intellectual disability. Am J Hum Genet. 2012; 90: 565-572.

91.Halgren C, Kjaergaard S, Bak M, Hansen C, El-Schich Z, Anderson CM, et al. Corpus callosum abnormalities, intellectual disability, speech impairment, and autism in patients with haploinsufficiency of ARID1B. Clin Genet. 2012; 82: 248-255.

92.Chen YK, Hsueh YP. Cortactin-binding protein 2 modulates the mobility of cortactin and regulates dendritic spine formation and maintenance. J Neurosci. 2012; 32: 1043-1055.

93.Harris KM, Stevens JK. Dendritic CA1 pyramidal cells in the rat hippocampus: serial electron microscopy with reference to their biophysical characteristics. J Neurosci. 1989; 9: 2982–2997.

94.Zhao X, Heng JI, Guardavaccaro D, Jiang R, Pagano M, Guillemot F, et al. The HECT-domain ubiquitin ligase Huwe1 controls neural differentiation and proliferation by destabilizing the N-Myc oncoprotein. Nat Cell Biol. 2008; 10: 643-653.

95.Zhao X, Arca D, Lim WK, Brahmachary M, Carro MS, Ludwig T, et al. The N-Myc-DLL3 cascade is suppressed by the ubiquitin ligase Huwe1 to inhibit proliferation and promote neurogenesis in the developing brain. Dev Cell. 2009; 17: 210-221.

96.Vriend J, Ghavami S, Marzban H. The role of the ubiquitin proteasome system in cerebellar development and medulloblastoma. Mol Brain. 2015; 8: 64.

97.Lumish HS, Wynn J, Devinsky O, Chung WK. Brief Report: SETD2 Mutation in a child with autism, intellectual disabilities and epilepsy. J Autism Dev Disord. 2015; 45: 3764-3770.

98.Rangasamy S, D'Mello SR, Narayanan V. Epigenetics, autism spectrum, and neurodevelopmental disorders. Neurotherapeutics. 2013; 10: 742-756.

99.Kathuria A, Nowosiad P, Jagasia R, Aigner S, Taylor RD, Andreae LC, et al. Stem cell-derived neurons from autistic individuals with SHANK3 mutation show morphogenetic abnormalities during early development. Mol Psychiatry. 2017; 23: 735-746.

100.Shcheglovitov A, Shcheglovitova O, Yazawa M, Portmann T, Shu R, Sebastiano V, et al. SHANK3 and IGF1 restore synaptic deficits in neurons from 22q13 deletion syndrome patients. Nature. 2013; 503: 267-271.

101.Iwase S, Lan F, Bayliss P, de la Torre-Ubieta L, Huarte M, Qi HH, et al. The X-linked mental retardation gene SMCX/JARID1C defines a family of histone H3 lysine 4 demethylases. Cell. 2007; 128: 1077-1088.

102.Dhar SS, Lee SH, Chen K, Zhu G, Oh W, Allton K, et al. An essential role for UTX in resolution and activation of bivalent promoters. Nucleic Acids Res. 2016; 44: 3659-3674.

103.Armoskus C, Moreira D, Bollinger K, Jimenez O, Taniguchi S, Tsai HW. Identification of sexually dimorphic genes in the neonatal mouse cortex and hippocampus. Brain Res. 2014; 1562: 23-38.

104.Vawter MP, Evans S, Choudary P, Tomita H, Meador-Woodruff J, Molnar M, et al. Gender-specific gene expression in post-mortem human brain: localization to sex chromosomes. Neuropsychopharmacology. 2004; 29: 373-384.

105.Blanco P, Sargent CA, Boucher CA, Mitchell M, Affara NA. Conservation of PCDHX in mammals; expression of human X/Y genes predominantly in brain. Mamm Genome. 2000; 11: 906-914.

106.Priddle TH, Crow TJ. Protocadherin 11X/Y a human-specific gene pair: an immunohistochemical survey of fetal and adult brains. Cereb Cortex. 2013; 23: 1933-1941.

107.Yan HT, Shinka T, Kinoshita K, Sato Y, Umeno M, Chen G, et al. Molecular analysis of TBL1Y, a Y-linked homologue of TBL1X related with X-linked late-onset sensorineural deafness. J Hum Genet. 2005; 50: 175-181.

108.Meyfour A, Ansari H, Pahlavan S, Mirshahvaladi S, Rezaei-Tavirani M, Gourabi H, et al. Y chromosome missing protein, TBL1Y, may play an important role in cardiac differentiation. J Proteome Res. 2017; 16: 4391-4402.

109.Ming X, Julu PO, Brimacombe M, Connor S, Daniels ML. Reduced cardiac parasympathetic activity in children with autism. Brain Dev. 2005; 27: 509-516.

110.Ming X, Patel R, Kang V, Chokroverty S, Julu PO. Respiratory and autonomic dysfunction in children with autism spectrum disorders. Brain Dev. 2016; 38: 225-232.

111.Pace M, Bricout VA. Low heart rate response of children with autism spectrum disorders in comparison to controls during physical exercise. Physiol Behav. 2015; 141: 63-68.

112.Lee KH, Song GJ, Kang IS, Kim SW, Paick JS, Chung CH, et al. Ubiquitin-specific protease activity of USP9Y, a male infertility gene on the Y chromosome. Reprod Fertil Dev. 2003; 15: 129-33.

113.Xu J, Burgoyne PS, Arnold AP. Sex differences in sex chromosome gene expression in mouse brain. Hum Mol Genet. 2002; 11: 1409-1419.

114.Walport LJ, Hopkinson RJ, Vollmar M, Madden SK, Gileadi C, Oppermann U, et al. Human UTY (KDM6C) is a male-specific Nϵ-methyl lysyl demethylase. J Biol Chem. 2014; 289: 18302-18313.

115.Dhar SS, Lee SH, Chen K, Zhu G, Oh W, Allton K, et al. An essential role for UTX in resolution and activation of bivalent promoters. Nucleic Acids Res. 2016; 44: 3659-3674.

116.Xu J, Deng X, Watkins R, Disteche CM. Sex-specific differences in expression of histone demethylases Utx and Uty in mouse brain and neurons. J Neurosci. 2008; 28: 4521-4527.

117.Mayer A, Lahr G, Swaab DF, Pilgrim C, Reisert I. The Y-chromosomal genes SRY and ZFY are transcribed in adult human brain. Neurogenetics. 1998; 1: 281-828.

118.Ota MO, Ndhlovu Z, Oh S, Piyasirisilp S, Berzofsky JA, Moss WJ, Griffin DE. Hemagglutinin protein is a primary target of the measles virus-specific HLA-A2-restricted CD8+ T cell response during measles and after vaccination. J Infect Dis. 2007; 195: 1799-1807.

119.Vogel C, Marcotte E. Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nat Rev Genet. 2012; 13: 227–232.

120.de Sousa Abreu R, Penalva LO, Marcotte E, Vogel C. Global signatures of protein and mRNA expression levels. Mol Biosyst. 2009; 5: 1512–1516.

121.Ronemus M, Iossifov I, Levy D, Wigler M. The role of de novo mutations in the genetics of autism spectrum disorders. Nat Rev Genet. 2014; 15(2):133-141.

122.Loke YJ, Hannan AJ, Craig JM. The Role of Epigenetic Change in Autism Spectrum Disorders. Front Neurol. 2015; 6: 107.

123.Sealey LA, Hughes BW, Sriskanda AN, Guest JR, Gibson AD, Johnson-Williams L, Pace DG, Bagasra O. Environmental factors in the development of autism spectrum disorders. Environ Int. 2016; 88: 288-298.

124.Shi L, Fatemi SH, Sidwell RW, Patterson PH. Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J Neurosci. 2003; 23(1):297-302.

125.Lucchese G, Kanduc D. Minimal immune determinants connect Zika virus, human Cytomegalovirus, and Toxoplasma gondii to microcephaly-related human proteins. Am J Reprod Immunol. 2017; 77: e12608.

126.Kanduc D, Shoenfeld Y. Inter-pathogen peptide sharing and the Original Antigenic Sin: Solving a paradox. Open Immunol J. 2018; 8: 16-27.

引用本文

Darja Kanduc*,Anna Polito. From Viral Infections to Autistic Neurodevelopmental Disorders via Cross-Reactivity, Journal of Psychiatry and Brain Science. 2018; 3; (6). https://doi.org/10.20900/jpbs.20180014.

文献评论

相关学者

相关机构